CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....
Phase 2, Phase 3
Cleveland, Ohio, United States and 61 other locations
the return of cancer in patients with a newly diagnosed or recurrent glioblastoma multiforme (GBM) in combination with standard che...
Phase 1, Phase 2
Cleveland, Ohio, United States and 4 other locations
This multi-site, Phase 1/2a clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen o...
Phase 1, Phase 2
Cleveland, Ohio, United States and 7 other locations
This research study is studying several investigational drugs as a possible treatment for Glioblastoma (GBM).The drugs involved in ...
Phase 2
Cleveland, Ohio, United States and 11 other locations
receptor (EGFR) resistance (EGFR C797S) mutations with or without CNS disease (in Phase 1 and Phase 2), or glioblastoma (GBM) expr...
Phase 1, Phase 2
Cleveland, Ohio, United States and 24 other locations
The purpose of this study is to establish the recommended phase 2 dose of eflornithine in combination with temozolomide in patients whose glioblastoma...
Phase 1
Cleveland, Ohio, United States and 7 other locations
This is a phase 2 study of oncolytic polio/rhinovirus recombinant (PVSRIPO) in adult patients with recurrent World Health Organization (WHO) grade IV...
Phase 2
Cleveland, Ohio, United States and 5 other locations
This study will investigate different doses of \[177Lu\]Lu-NeoB in combination with RT and TMZ in participants with newly diagnosed glioblastoma...
Phase 1
Cleveland, Ohio, United States and 14 other locations
* To evaluate the safety and tolerability of escalating doses of ERAS-801 in study participants with recurrent glioblastoma multiforme (GBM...
Phase 1
Cleveland, Ohio, United States and 7 other locations
This clinical trial is testing the safety and efficacy of NanO2TM administered via intravenous infusion in combination with standard radiation and ch...
Phase 2
Cleveland, Ohio, United States and 9 other locations
Clinical trials
Research sites
Resources
Legal